Premium
The Need for Multiple Doses of 400 mg Ketoconazole as a Precipitant Inhibitor of a CYP3A Substrate in an In Vivo Drug‐Drug Interaction Study
Author(s) -
Oo Charles,
Chen YaChi
Publication year - 2009
Publication title -
the journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.92
H-Index - 116
eISSN - 1552-4604
pISSN - 0091-2700
DOI - 10.1177/0091270008325931
Subject(s) - ketoconazole , cyp3a , in vivo , pharmacology , pharmacokinetics , drug interaction , drug , chemistry , cytochrome p450 , medicine , biology , enzyme , biochemistry , antifungal , microbiology and biotechnology , dermatology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom